Sofinnova PartnersTHE DEAL, AT A GLANCE
From the announcementAlethio
Who is involvedBacked by Sofinnova Partners, RA Capital, Janus Henderson Investors, Redmile GroupFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedAlethio raised Series A, announced 2026-11-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersAlethio is advancing ATX-011 as a potential replacement for chemotherapy used to treat essential thrombocythemia, a chronic blood cancer characterized by excess…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Alethio · Financing Record
Explore source-linked visual explanations for Alethio. Unsupported claims are withheld while source review continues.
Record 15394 · Recorded date: 2026-11-05
Explore company records →